Product Information
METHYLPREDNISOLONE 4 MG TABLET is a generic product labeled by BluePoint Laboratories, priced at $0.1324 per EA under NDC 68001055700. Its NADAC has been published 163 times since Feb 22, 2023.
FDA first approved this application on Oct 31, 1997. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001055700
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
3/18/2026
Active Ingredients
METHYLPREDNISOLONEApproval Type
Generic (ANDA)
FDA Application
ANDA040189FDA Approved
10/31/1997
TE Code
AB
On Market Since
1/31/2023
Pharmacological Classes
Price Statistics
The NADAC for METHYLPREDNISOLONE 4 MG TABLET has been published 163 times since Feb 22, 2023, and over the history we have for it it has declined 11.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1324 per EA |
|---|---|
| All-time high | $0.1956 (Apr 10, 2024) |
| All-time low | $0.1105 (Nov 20, 2024) |
| 52-week high | $0.1606 |
| 52-week low | $0.1324 |
| Median price | $0.1495 |
| Average price | $0.1485 |
| Largest weekly change | -32.7% (Apr 17, 2024) |
| Weeks tracked | 163 |
| Tracking since | Feb 22, 2023 |
1W
N/A
1M
N/A
3M
N/A
6M
-5.7%
1Y
-17.6%
3Y
-16.2%
5Y
N/A
All
-11.0%
Last surveyed Apr 1, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 13% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METHYLPREDNISOLONE 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPREDNISOLONE 4 MG TABLET, manufactured by BluePoint Laboratories, is $0.1324 per EA (NDC 68001055700), effective Apr 1, 2026.
How has the price of METHYLPREDNISOLONE 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHYLPREDNISOLONE 4 MG TABLET has declined 11.0%. It has been tracked across 163 weekly CMS publications since Feb 22, 2023.
What are the highest and lowest recorded NADAC prices for METHYLPREDNISOLONE 4 MG TABLET?
Since Feb 22, 2023, the NADAC for METHYLPREDNISOLONE 4 MG TABLET has ranged from a low of $0.1105 (Nov 20, 2024) to a high of $0.1956 (Apr 10, 2024), with a median of $0.1495 per EA.
Are there cheaper alternatives to METHYLPREDNISOLONE 4 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METHYLPREDNISOLONE 4 MG DOSEPK, is $0.1155 per EA — about 13% below METHYLPREDNISOLONE 4 MG TABLET.
Who manufactures METHYLPREDNISOLONE 4 MG TABLET?
METHYLPREDNISOLONE 4 MG TABLET (NDC 68001055700) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.